These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1394233)

  • 21. Somatostatin receptors in the gastrointestinal tract in health and disease.
    Reubi JC
    Yale J Biol Med; 1992; 65(5):493-503; discussion 531-6. PubMed ID: 1340064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma.
    Obara W; Konda R; Akasaka S; Nakamura S; Sugawara A; Fujioka T
    J Urol; 2007 Oct; 178(4 Pt 1):1497-503. PubMed ID: 17707062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
    Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
    Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The histopathological heterogeneity of small renal cell carcinoma.
    Wunderlich H; Schlichter A; Kosmehl H; Schubert J
    Anticancer Res; 1999; 19(2C):1497-500. PubMed ID: 10365131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
    Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
    Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of somatostatin receptors in peritumoral veins of human tumors.
    Denzler B; Reubi JC
    Cancer; 1999 Jan; 85(1):188-98. PubMed ID: 9921992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo inaccessibility of somatostatin receptors to 111In-pentreotide in primary renal cell carcinoma.
    Montravers F; Rousseau C; Doublet JD; Gattengo B; Allard S; Fouret P; Bernaudin JF; Thibault P; Talbot JN
    Nucl Med Commun; 1998 Oct; 19(10):953-61. PubMed ID: 10234675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of renin in chromophobe renal cell carcinomas].
    Arias LF; Bruneval P; Blanco J
    Actas Urol Esp; 2010 Sep; 34(8):694-8. PubMed ID: 20800033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin receptors in human colorectal cancer.
    Iftikhar SY; Thomas WM; Rooney PS; Morris DL
    Eur J Surg Oncol; 1992 Feb; 18(1):27-30. PubMed ID: 1346594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors.
    Reubi JC; Waser B; Sheppard M; Macaulay V
    Int J Cancer; 1990 Feb; 45(2):269-74. PubMed ID: 1968052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction?
    Reubi JC; Horisberger U; Laissue J
    Int J Cancer; 1994 Mar; 56(5):681-8. PubMed ID: 8314345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor receptor content in human renal cell carcinomas.
    Yoshida K; Tosaka A; Takeuchi S; Kobayashi N
    Cancer; 1994 Apr; 73(7):1913-8. PubMed ID: 8137218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer.
    Reubi JC; Torhorst J
    Cancer; 1989 Sep; 64(6):1254-60. PubMed ID: 2569925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas.
    Reubi JC; Horisberger U; Essed CE; Jeekel J; Klijn JG; Lamberts SW
    Gastroenterology; 1988 Sep; 95(3):760-3. PubMed ID: 2899530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue.
    Reubi JC; Horisberger U; Waser B; Gebbers JO; Laissue J
    Gastroenterology; 1992 Oct; 103(4):1207-14. PubMed ID: 1356871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substance-P receptors in human primary neoplasms: tumoral and vascular localization.
    Hennig IM; Laissue JA; Horisberger U; Reubi JC
    Int J Cancer; 1995 Jun; 61(6):786-92. PubMed ID: 7790112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor and epidermal growth factor receptor therapies in renal cell carcinoma: do we need a better mouse trap?
    Dancey JE
    J Clin Oncol; 2004 Aug; 22(15):2975-7. PubMed ID: 15210735
    [No Abstract]   [Full Text] [Related]  

  • 39. Local up-regulation of neuropeptide receptors in host blood vessels around human colorectal cancers.
    Reubi JC; Mazzucchelli L; Hennig I; Laissue JA
    Gastroenterology; 1996 Jun; 110(6):1719-26. PubMed ID: 8964396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin receptors in human gastrointestinal cancer.
    Dy D; Morris D
    Int J Oncol; 1993 Sep; 3(3):519-23. PubMed ID: 21573394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.